Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
22nd Annual Women’s Health Annual Visit (WHAV)
Multiple dates & locations available
Target Locked in gMG: Why T2T Matters
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Minimal By Design: Define MSE Endpoints
Shared Goals, Shared Gains: Align With Patient Preferences
Escalate With Intention: Stepwise, Target-Anchored Moves
The 2-Point Signal: Apply ≥2-Point Rule
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
The IgG Clock: Redose Using IgG Kinetics
When to Begin FcRn: Initiation Criteria, Key Evidence
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Clinical Considerations for the Diagnosis of Endometriosis
Linda Bradley, MD
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Lee P. Shulman, MD, FACMG, FACOG
Samantha Denäe
Pre- and Postoperative Use of GnRH Antagonists
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Turning Flares Into Function: Flag Uncontrolled Disease
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Melissa Simon, MD
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Casey Joe Hinds
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
Alloimmune Neutropenia of the Fetus and Newborn
Masja de Haas, MD, PhD
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.